• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHVF

Recent news which mentions RHHVF

< Previous 1 2 3 4 5 Next >
FDA Approves Expanded Use Of Roche's Influenza Treatment
August 12, 2022
Tickers RHHBF RHHBY RHHVF
Tags General RHHVF News
From Benzinga
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
August 08, 2022
Tickers AMGN MRK RHHBF RHHBY
Tags Health Care Market News AMGN
From Benzinga
Poseida Shares Rally As Roche Takes Next Big Step Into Allogeneic CAR-T Field
August 03, 2022
Tickers PSTX RHHBF RHHBY RHHVF
Tags Penny Stocks PSTX Briefs
From Benzinga
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
July 25, 2022
Tickers REGN RHHBF RHHBY RHHVF
Tags News RHHVF General
From Benzinga
Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners
July 21, 2022
Tickers ABBV ABUS ASMB HLVX
Tags OLMA VERV ABUS
From Benzinga
Roche's Long-Time CEO Passes Baton, Higher Diagnostics, Medicine Sales Lift 1H Sales & Profit
July 21, 2022
Tickers RHHBF RHHBY RHHVF
Tags Benzinga Biotech Guidance
From Benzinga
Roche Launches Dual Antigen & Antibody Hepatitis C Diagnostic Test
July 18, 2022
Tickers RHHBF RHHBY RHHVF
Tags Health Care RHHBF Briefs
From Benzinga
New Data Reinforce Favorable Safety, Efficacy Of Roche's Hemlibra For Hemophilia A
July 11, 2022
Tickers RHHBF RHHBY RHHVF
Tags Briefs RHHBF RHHBY
From Benzinga
Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial
July 06, 2022
Tickers RHHBF RHHBY RHHVF SRPT
Tags Market News gene therapy Movers
From Benzinga
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
July 06, 2022
Tickers AMTI BIIB ESALF ESALY
Tags General RHHVF PHGE
From Benzinga
Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients
June 16, 2022
Tickers ACIU RHHBF RHHBY RHHVF
Tags Health Care Trading Ideas Market News
From Benzinga
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
June 06, 2022
Tickers BNTX MRK RHHBF RHHBY
Tags RHHBY Pancreatic Cancer RHHVF
From Benzinga
Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer
May 23, 2022
Tickers MRK RHHBF RHHBY RHHVF
Tags Benzinga Biotech Market News
From Benzinga
Genentech's Tiragolumab/Tecentriq Fails On Progression Free Survival In PD-L1-High Metastatic Lung Cancer
May 11, 2022
Tickers RHHBF RHHBY RHHVF
Tags RHHBF Briefs Health Care
From Benzinga
Roche Releases More Evrysdi Data For Very Young Infants With SMA
April 29, 2022
Tickers RHHBF RHHBY RHHVF
Tags Health Care RHHBF Briefs
From Benzinga
Roche's CEO Warns Russia-Ukraine War Causing Problems For Multiple Sclerosis Trials
April 25, 2022
Tickers RHHBF RHHBY RHHVF
Tags RHHBF Briefs Health Care
From Benzinga
COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook
April 25, 2022
Tickers RHHBF RHHBY RHHVF
Tags Health Care Benzinga Biotech
From Benzinga
EMA' Advisory Committee Recommends Approval For Roche's Two Cancer Drugs
April 22, 2022
Tickers RHHBF RHHBY RHHVF
Tags Health Care European Medicines Agency Market News
From Benzinga
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
April 20, 2022
Tickers A ILMN MYGN NTRA
Tags Market News Benzinga Health Care
From Benzinga
Read Why Pliant Therapeutics Shares Are Soaring Today
April 13, 2022
Tickers PLRX RHHBF RHHBY RHHVF
Tags Market News PLRX Movers
From Benzinga
Genentech's Ocrevus Shows Benefit In Disability Progression & Cognitive Decline In Multiple Sclerosis
April 04, 2022
Tickers RHHBF RHHBY RHHVF
Tags Large Cap General News
From Benzinga
FDA Grants Priority Review To Roche's Actemra For Hospitalized COVID-19 Adults
April 04, 2022
Tickers RHHBF RHHBY RHHVF
Tags FDA Health Care Biotech
From Benzinga
Roche's Tiragolumab Immunotherapy Flunks In Late-Stage Lung Cancer Trial
March 30, 2022
Tickers RHHBF RHHBY RHHVF
Tags RHHBF Health Care RHHBY
From Benzinga
Drug makers, Scientists Working For Long COVID Treatments: Reuters
March 25, 2022
Tickers AXLA GSK HGEN MRNA
Tags RHHBY COVID/19 Coronavirus PFE
From Benzinga
Roche's Evrysdi Shows Long-Term Efficacy, Safety In Broader Spinal Muscular Atrophy Population
March 16, 2022
Tickers PTCT RHHBF RHHBY RHHVF
Tags General News RHHVF
From Benzinga
Exelixis Will Not Pursue Untreated Liver Cancer Indication For Cabometyx Combo Therapy
March 15, 2022
Tickers BAYRY BAYZF EXEL IPSEY
Tags RHHBY General RHHVF
From Benzinga
Sanofi-Regeneron's Dupixent Falls Short In Chronic Spontaneous Urticaria Trial
February 18, 2022
Tickers ANY NVS REGN RHHBF
Tags RHHBF SNY Briefs
From Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
February 03, 2022
Tickers NVS RHHBF RHHBY RHHVF
Tags NVS RHHBF Briefs
From Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
February 02, 2022
Tickers NVS RHHBF RHHBY RHHVF
Tags Health Care Market News Guidance
From Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
February 01, 2022
Tickers BIIB RHHBF RHHBY RHHVF
Tags RHHVF News General
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap